Overview

An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans

Status:
Completed

Trial end date:
2004-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether prophylactic use of topiramate (preventative use before a migraine attack) enhances the effectiveness of migraine treatment with triptans.

Phase:

Phase 2

Details

Lead Sponsor:

Janssen-Ortho Inc., Canada

Treatments:

Topiramate